Top Page
British American Tobacco
(LSE:BATS)
British American Tobacco (BATS) vs. S&P 500 (SPY)
British American Tobacco Business Overview & Revenue Model
British American Tobacco Financial Statement Overview
| Breakdown | |||||
| TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 33.10B | 25.87B | 27.28B | 27.66B | 25.68B | 25.78B | Gross Profit |
| 26.97B | 21.43B | 22.39B | 23.10B | 21.09B | 21.33B | EBIT |
| -14.08B | 2.74B | -15.75B | 10.52B | 10.91B | 10.94B | EBITDA |
| 16.17B | 7.74B | 13.28B | 11.59B | 11.19B | 10.71B | Net Income Common Stockholders |
| -23.01B | 3.07B | -14.37B | 6.67B | 6.80B | 6.40B |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 4.13B | 5.81B | 5.26B | 4.03B | 3.27B | 3.38B | Total Assets |
| 146.07B | 118.90B | 118.72B | 153.55B | 137.37B | 137.69B | Total Debt |
| 42.17B | 0.00 | 39.73B | 43.14B | 39.66B | 43.97B | Net Debt |
| 38.49B | -5.30B | 35.07B | 39.69B | 36.85B | 40.83B | Total Liabilities |
| 73.44B | 68.90B | 65.78B | 77.84B | 69.96B | 74.73B | Stockholders Equity |
| 72.30B | 49.64B | 52.57B | 75.37B | 67.10B | 62.67B |
| Cash Flow | Free Cash Flow | ||||
| 13.53B | 9.52B | 10.25B | 9.87B | 9.19B | 9.28B | Operating Cash Flow |
| 14.17B | 10.13B | 10.71B | 10.39B | 9.72B | 9.79B | Investing Cash Flow |
| 2.19B | 1.38B | -296.00M | -705.00M | -1.14B | -783.00M | Financing Cash Flow |
| -12.79B | -10.63B | -9.31B | -8.88B | -8.75B | -7.90B |
British American Tobacco Technical Analysis
British American Tobacco Risk Analysis
British American Tobacco Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £117.64B | 24.06 | 30.27% | 3.15% | -0.76% | -12.83% | |
80 Outperform | £23.27B | 9.40 | 45.59% | 5.43% | 2.26% | 19.15% | |
75 Outperform | £34.68B | 24.96 | 18.88% | 3.86% | -3.00% | -11.12% | |
72 Outperform | £57.57B | 22.44 | 19.06% | 4.30% | 3.46% | -48.06% | |
69 Neutral | £68.07B | 22.69 | 5.92% | 7.59% | -5.19% | ― | |
62 Neutral | $20.22B | 13.99 | -16.14% | 3.22% | 1.15% | 3.41% |
British American Tobacco Earnings Call Summary
British American Tobacco Corporate Events
British American Tobacco PLC announced the purchase of 128,977 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted with UBS AG, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and interests.
British American Tobacco has announced that several of its executive directors and other key managerial personnel have purchased ordinary shares under the Partnership Share Scheme, a HMRC-approved Share Incentive Plan. This move, involving the acquisition of shares at a price of £31.83013 each, reflects the company’s commitment to aligning the interests of its leadership with those of its shareholders, potentially strengthening stakeholder confidence and reinforcing its market position.
British American Tobacco announced the repurchase of 130,448 of its ordinary shares as part of its ongoing buyback program. This transaction, authorized by shareholders, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and interest notifications under regulatory guidelines.
British American Tobacco has announced the release and subsequent sale of shares under its 2022 International Share Reward Scheme. This notification involves several key managerial figures, including directors and regional directors, who have been allocated shares as part of their compensation package. The transactions, conducted outside a trading venue, reflect the company’s ongoing commitment to reward its management team, potentially impacting its financial reporting and stakeholder relations.
British American Tobacco has announced the award of ordinary shares to several executive directors and key managerial personnel under its 2025 Share Reward Scheme. This move, involving notable figures such as the Chief Executive and Chief Financial Officer, underscores the company’s commitment to incentivizing its leadership team, potentially impacting its operational focus and aligning management interests with those of shareholders.
British American Tobacco has repurchased 129,815 of its ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move reduces the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests in line with regulatory requirements.
British American Tobacco announced the release of 67,109 ordinary shares to its Chief Executive, Tadeu Marroco, under the 2020 Long-Term Incentive Plan. Additionally, 31,544 shares were sold to cover tax liabilities associated with the vesting of this plan, generating approximately £1,003,730.08. This transaction highlights the company’s ongoing commitment to rewarding its executives while managing financial obligations effectively.
British American Tobacco p.l.c. announced the purchase of 128,601 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted through UBS AG, is part of a strategy to manage the company’s capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in circulation and potentially impacting shareholder voting rights. This move reflects the company’s efforts to optimize its financial operations and maintain a strong market position.
British American Tobacco has announced its issued share capital as of March 31, 2025, which consists of over 2.2 billion ordinary shares with voting rights. The company also holds over 133 million shares in treasury. This information is crucial for shareholders to determine their voting rights interest or any changes to it, in compliance with the FCA’s Disclosure Guidance and Transparency Rules.
British American Tobacco has disclosed a transaction involving James Murphy, Director of Research and Science, who transferred 6,202 ordinary shares between his own accounts at nil consideration. This internal transaction, conducted outside a trading venue, reflects routine managerial adjustments and is unlikely to have significant implications for stakeholders or the company’s market positioning.
British American Tobacco has executed a share buyback program, purchasing 130,932 of its ordinary shares at an average price of 3,131.3859 pence per share. The company intends to cancel these shares, which will result in a total of 2,202,512,986 ordinary shares in issue, excluding treasury shares. This move is part of a strategy to optimize the capital structure and potentially enhance shareholder value.
British American Tobacco has announced the release of ordinary shares under its 2022 Restricted Share Plan to several key executives, including Jerome Abelman, James Barrett, Luciano Comin, and Michael Dijanosic. These transactions, which include sales to cover tax liabilities, reflect the company’s ongoing efforts to manage executive compensation and align management interests with shareholder value, potentially impacting the company’s financial strategies and stakeholder relations.
British American Tobacco announced the release and subsequent sale of shares under its 2022 Long-Term Incentive Plan for several key executives. This move involves the distribution of ordinary shares to directors and officers, such as Jerome Abelman, James Barrett, Luciano Comin, and Michael Dijanosic, with some shares sold to cover tax liabilities. The transactions, conducted outside a trading venue, reflect the company’s ongoing efforts to align executive compensation with long-term performance goals, potentially impacting shareholder value and executive engagement.
British American Tobacco announced the release of ordinary shares under the 2022 Deferred Share Bonus Scheme to several executives, including the Chief Executive and other directors. These transactions, which involved both the release and subsequent sale of shares to cover tax liabilities, highlight the company’s ongoing commitment to executive compensation and financial management strategies. The impact of these transactions on the company’s operations or market positioning is not explicitly detailed in the release, but such moves are typically part of broader efforts to align management incentives with shareholder interests.
British American Tobacco p.l.c. has executed a share buyback transaction, purchasing 132,272 of its ordinary shares from UBS AG as part of its ongoing buyback program. This move is intended to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing the value of remaining shares. Following the cancellation of the purchased shares, the company will have 2,202,404,061 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under FCA regulations.
British American Tobacco has announced a change in major holdings, with Spring Mountain Investments Ltd acquiring a significant percentage of voting rights. This acquisition, which crosses a notable threshold, may impact the company’s governance and influence its strategic decisions, reflecting a shift in stakeholder dynamics.
British American Tobacco announced the repurchase of 112,000 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted through UBS AG, reflects the company’s strategy to manage its share capital and potentially enhance shareholder value. Following this purchase, the company will have over 2.2 billion ordinary shares in issue, excluding treasury shares, which may impact shareholder interests and regulatory disclosures.
British American Tobacco p.l.c. has executed a share buyback, purchasing 112,000 of its ordinary shares as part of a program authorized by shareholders. The shares, bought at an average price of 3,149.7854 pence, will be canceled, reducing the total number of shares in circulation and potentially enhancing shareholder value. This move aligns with the company’s strategy to optimize its capital structure and return value to shareholders.
British American Tobacco p.l.c. announced the repurchase of 112,000 of its ordinary shares as part of its buyback program. The shares were purchased at prices ranging from 3,151.00 to 3,177.00 pence and will be canceled, reducing the number of shares in issue. This move is part of the company’s strategy to manage its capital structure and return value to shareholders, potentially impacting shareholder interests and market perception.
British American Tobacco announced the purchase of 111,475 of its ordinary shares as part of a buyback program authorized by shareholders. This transaction, conducted through UBS AG, is part of a strategy to manage the company’s capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and require notifications under regulatory rules.
British American Tobacco has announced the granting of conditional share awards to several key managerial personnel under its Restricted Share Plan. These awards, priced at 3,179 pence per share, will vest after three years without further performance conditions, reflecting the company’s commitment to incentivizing its leadership team. This move is likely to strengthen the alignment of managerial interests with shareholder value, potentially impacting the company’s operational focus and stakeholder confidence.
British American Tobacco announced the granting of conditional share awards to its senior management under the Long Term Incentive Plan. These awards, which were granted at a price of 3,179 pence per share, will vest in three years subject to performance conditions. This move is part of the company’s strategy to incentivize its leadership team, potentially impacting its operational focus and aligning management interests with shareholder value.
British American Tobacco has announced the granting of conditional share awards to its executive directors and other key managerial personnel under the Deferred Share Bonus Scheme. These awards, priced at 3,179 pence per share, will vest after three years without additional performance conditions. This move is part of the company’s strategy to incentivize and retain top management talent, potentially impacting its operational efficiency and market positioning.
British American Tobacco p.l.c. has executed a buyback of 111,000 ordinary shares as part of its ongoing share repurchase program. This transaction, conducted with UBS AG, reflects the company’s strategy to optimize its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
British American Tobacco has executed a share buyback, purchasing 108,258 of its ordinary shares as part of a previously announced program. The company intends to cancel these shares, which will result in a reduction of its total shares in issue, potentially impacting shareholder interests and voting rights.
British American Tobacco announced the purchase of 109,000 of its own shares as part of a buyback program, with plans to cancel these shares. This transaction, executed through UBS AG, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value. The buyback reduces the number of shares in circulation, which can impact voting rights and shareholder notifications under regulatory guidelines.
British American Tobacco announced the repurchase of 109,000 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted through UBS AG, is part of the company’s strategy to manage its capital structure and return value to shareholders. The repurchased shares will be canceled, reducing the total number of shares in circulation and potentially impacting shareholder voting rights and interests.
British American Tobacco has announced the finalization details for its May 2025 dividend, part of a series of quarterly dividends declared for the year ending December 2024. The dividend, amounting to 60.06p per ordinary share, will be distributed to shareholders on the UK and South Africa registers, with South African shareholders receiving their dividends in rand. The exchange rate for the conversion has been set, and the applicable South Africa Dividends Tax will be withheld unless exemptions apply. This announcement underscores the company’s commitment to returning value to its shareholders while navigating the complexities of international taxation and currency exchange.
British American Tobacco has announced the finalization details for its May 2025 dividend payment, part of a series of quarterly dividends declared for the year ending December 2024. Shareholders on the South Africa branch register will receive dividends in rand, with the exchange rate set at £:R=23.7081, resulting in a net dividend of 1139.12679 SA cents per share after a 20% South Africa Dividends Tax. This announcement underscores the company’s commitment to maintaining shareholder value and provides clarity on the financial implications for its South African stakeholders.
British American Tobacco announced the repurchase of 108,728 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted with UBS AG, aims to cancel the purchased shares, thereby reducing the total number of shares in circulation and potentially increasing shareholder value. Following this transaction, the company will have 2,203,524,719 ordinary shares in issue, excluding treasury shares, which carry voting rights. This move is part of the company’s strategy to manage its capital structure and deliver value to its shareholders.
British American Tobacco has announced the approval and publication of a Base Prospectus for its £25 billion Euro Medium Term Note Programme. This development, approved by the Financial Conduct Authority, is a significant step in BAT’s financial strategy, potentially impacting its market positioning and providing opportunities for stakeholders to engage with the company’s financial instruments.
British American Tobacco has announced the publication of its Notice of Annual General Meeting 2025, which is available on its website. The company has also made available its Annual Report and Form 20-F 2024, a Combined Performance and Sustainability Summary, and various proxy forms for shareholders. These documents are in compliance with UK Listing Rules and JSE requirements, and are accessible via the company’s website and the Financial Conduct Authority’s National Storage Mechanism. This announcement is significant for stakeholders as it outlines the company’s compliance with regulatory requirements and provides essential information for shareholders ahead of the AGM.
British American Tobacco p.l.c. announced the purchase of 109,339 of its ordinary shares as part of its buyback program. The shares were bought at prices ranging from 3,152.00 to 3,186.00 pence per share, with the company planning to cancel them. This transaction will reduce the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests.
British American Tobacco has announced the pricing of a $2.5 billion notes offering through its subsidiary, B.A.T Capital Corporation. The offering includes three sets of notes with varying maturities and interest rates, and is expected to close on March 13, 2025. The proceeds from this offering will be used for general corporate purposes, including the potential repayment of existing debt. This strategic move is likely to strengthen BAT’s financial position and support its ongoing transition towards smokeless products, reflecting its commitment to evolving consumer preferences.
British American Tobacco p.l.c. announced the purchase of 110,622 of its ordinary shares as part of a buyback program authorized by shareholders. The shares were bought at prices ranging from 3,114 to 3,164 pence and will be canceled, reducing the total number of shares in issue. This move is part of the company’s strategy to optimize its capital structure and return value to shareholders.
British American Tobacco has announced the grant of options over ordinary shares to key executives under its 2025 three-year Sharesave Scheme. This move involves Chief Executive Tadeu Marroco, Chief Financial Officer Soraya Benchikh, and Director of Corporate and Regulatory Affairs Paul McCrory, reflecting the company’s strategy to align management incentives with shareholder interests.
British American Tobacco has executed a share buyback transaction, purchasing 110,000 of its ordinary shares as part of its ongoing buyback program. The company intends to cancel these shares, which will adjust the total number of shares in issue and may impact shareholder notifications under regulatory guidelines.
British American Tobacco has executed a share buyback, purchasing 108,665 of its ordinary shares as part of its ongoing buyback program. This move is intended to reduce the number of shares in circulation, potentially increasing the value of remaining shares and reflecting the company’s commitment to returning value to shareholders.
British American Tobacco announced the repurchase of 110,000 of its ordinary shares as part of its ongoing buyback program. This move, authorized by shareholders, aims to enhance shareholder value by reducing the number of shares in circulation, potentially increasing the value of remaining shares and strengthening the company’s market position.
British American Tobacco p.l.c. announced a buyback of 109,855 ordinary shares as part of its ongoing share repurchase program. This move, executed through UBS AG, is intended to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing the value of remaining shares. Following this transaction, the company will have 2,204,292,842 ordinary shares in issue and 133,255,156 shares held in treasury, impacting the company’s capital structure and potentially influencing shareholder decisions under the FCA’s Disclosure Guidance and Transparency Rules.
British American Tobacco has announced the purchase of 112,000 of its ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This transaction, executed through UBS AG, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value, impacting the number of shares in circulation and voting rights.
British American Tobacco has announced its share capital and voting rights as of 28 February 2025. The company reported an issued share capital of 2,204,628,148 ordinary shares with voting rights, while holding 133,255,156 shares in treasury. This information is crucial for shareholders to calculate their voting rights interests under the FCA’s Disclosure Guidance and Transparency Rules.
British American Tobacco announced the purchase of 113,451 of its ordinary shares as part of its ongoing buyback program. The company intends to cancel these shares, which will result in a total of 2,204,514,697 ordinary shares in issue. This move is part of a strategy to enhance shareholder value and may impact the company’s market positioning by reducing the number of shares available in the market.
British American Tobacco has announced a new block listing application for 1,500,000 ordinary shares to be admitted to the London Stock Exchange, expected to commence trading on 3 March 2025. This move is part of the company’s Sharesave Scheme, allowing shares to rank equally with existing ones. Concurrently, the company has cancelled a previous block listing under its Executive Share Option Scheme, as all outstanding options have been exercised, marking the closure of that scheme.
British American Tobacco p.l.c. has executed a share buyback program, purchasing 113,108 of its ordinary shares from UBS AG, with plans to cancel these shares. This move, in line with shareholder authorization, will reduce the total number of shares in circulation, potentially impacting shareholder value and market perception.
British American Tobacco p.l.c. announced the repurchase of 114,000 of its ordinary shares as part of its ongoing buyback program. The shares were acquired at prices ranging from 3,007.00 to 3,032.00 pence and will be canceled, reducing the total number of shares in circulation. This move is part of the company’s strategy to enhance shareholder value and optimize its capital structure.
British American Tobacco announced the repurchase of 114,005 ordinary shares as part of its ongoing buyback program, with prices ranging from 2,944.00 to 3,022.00 pence per share. The company plans to cancel these shares, which will impact the total shares in issue and treasury, potentially affecting shareholder interests in line with regulatory requirements.
British American Tobacco p.l.c. has executed a transaction to repurchase 115,000 of its ordinary shares, as part of an ongoing buyback programme. This buyback is intended to cancel the shares, effectively reducing the total number of shares in circulation and potentially increasing the value of remaining shares, which could benefit shareholders.
British American Tobacco announced the repurchase of 114,466 of its ordinary shares as part of a buyback program, with plans to cancel these shares. This transaction will reduce the number of shares in issue, potentially impacting shareholder interests and trading dynamics under the FCA’s disclosure rules.
British American Tobacco has released a Supplementary Prospectus for its £25 billion Euro Medium Term Note Programme, approved by the Financial Conduct Authority. This marks a significant step in BAT’s financial operations, aimed at enhancing its funding capabilities and supporting its strategic initiatives, which could impact its market positioning and investor relations.
British American Tobacco has completed a transaction to repurchase 129,968 of its ordinary shares as part of a buyback program authorized by shareholders in 2024. This move is expected to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing earnings per share. Following this transaction, the company will have approximately 2.2 billion shares in issue, with a portion held in treasury, facilitating better control over company equity and maintaining market stability.
British American Tobacco announced the repurchase of 124,484 of its ordinary shares from UBS AG as part of its ongoing buyback program. This transaction is intended to optimize the company’s capital structure and provide value to shareholders by canceling the purchased shares, thereby reducing the total number of shares in issue and potentially enhancing shareholder value.
British American Tobacco has executed a share buyback, repurchasing 129,000 ordinary shares at an average price of 3,086.0470 pence per share. This move is part of its previously announced buyback program and aims to enhance shareholder value by reducing the number of shares in circulation. The purchase and subsequent cancellation of the shares will result in the company having 2,205,558,002 ordinary shares in issue, excluding treasury shares, which could impact shareholder voting rights and interests.
British American Tobacco has published its 2024 Annual Report and associated documents, highlighting its financial and sustainability performance. The company has identified key risks, including competition from illicit trade and geopolitical tensions, which could impact its strategic objectives and market operations, emphasizing ongoing efforts to mitigate these risks.
British American Tobacco p.l.c. has executed a buyback of 128,500 ordinary shares as part of its ongoing share repurchase program. The transaction, completed on February 13, 2025, intends to cancel the purchased shares, reducing the number of shares in circulation and potentially increasing shareholder value. This move is part of the company’s strategy to manage its capital structure and return value to its shareholders.
British American Tobacco has made a public disclosure regarding a transaction involving its Chief Executive, Tadeu Marroco, and Luciana Franco Do Amaral, who is closely associated with him. The transaction involved the acquisition of ordinary shares through the reinvestment of dividend income, reflecting a strategic move in their shareholding. This transaction, conducted on the London Stock Exchange, underscores the ongoing investment and engagement of the company’s top executives in its financial activities, potentially influencing stakeholder perceptions and market confidence.
British American Tobacco announced a share buyback program commencing on 13 February 2025, with UBS AG London Branch appointed to independently manage the share purchases until 30 April 2025. The program aims to reduce the company’s share capital by repurchasing and canceling up to 223,642,156 shares, subject to shareholder approval and regulatory compliance, potentially impacting shareholder value positively.
British American Tobacco has executed a buyback of 99,582 of its ordinary shares as part of its ongoing repurchase program, with plans to cancel the purchased shares. This transaction aims to consolidate the company’s share base, potentially enhancing shareholder value and signaling confidence in its financial position.
British American Tobacco reported its preliminary results for 2024, highlighting a strategic shift towards smokeless products which now contribute 17.5% of its revenue. Despite a 5.2% decline in total revenue due to the sale of its Russian and Belarusian businesses and currency impacts, the company saw a 1.3% increase in organic revenue driven by an 8.9% boost in New Categories. Investments in the U.S. market and Europe are showing positive returns, especially in the modern oral segment, despite challenges posed by illicit vapour products. The company expects regulatory headwinds but remains committed to its transformation strategy, aiming for sustainable growth and shareholder returns.
British American Tobacco has announced the repurchase of 115,616 ordinary shares as part of its ongoing buyback program. The shares were purchased at prices ranging between 3,375.00p and 3,414.00p and will be cancelled following the transaction. This move is expected to impact the company’s share capital and could potentially affect shareholder voting rights.
British American Tobacco announced the buyback of 116,867 ordinary shares as part of its ongoing share repurchase program, a move authorized by shareholders. The purchased shares will be canceled, reducing the total number of shares in issue and potentially impacting shareholder voting rights and interests.
British American Tobacco has announced a notification regarding major holdings, indicating a change in voting rights held by The Capital Group Companies, Inc. The notification reveals that The Capital Group Companies now holds 16.103223% of the voting rights in BAT, reflecting an increase from a previous position of 15.075429%. This change signifies an important shift in shareholder composition, which could influence future corporate decisions and strategies.
British American Tobacco has announced changes to its Board and Committees with the appointment of Uta Kemmerich-Keil as an independent Non-Executive Director effective from February 17, 2025. Uta’s extensive management experience in regulated industries and strategic transformation will support BAT’s goal of building a Smokeless World. Concurrently, Murray S. Kessler will step down to focus on his new role as CEO of Wellington International LLC. These changes have prompted a review of the Company’s Board Committees, leading to adjustments in membership roles.
British American Tobacco announced the repurchase of 120,697 ordinary shares as part of its ongoing buyback program, following shareholder approval. This transaction, conducted through Merrill Lynch International, is part of the company’s strategy to manage its capital structure effectively, potentially impacting shareholder value positively by reducing the number of shares in circulation.
British American Tobacco has executed a share buyback transaction, purchasing 121,905 of its ordinary shares at an average price of 3,321.7461 pence per share. The company intends to cancel these shares, thereby reducing the number of shares in circulation, which could potentially increase the value of remaining shares and improve shareholder returns. This action aligns with the company’s strategic efforts to enhance shareholder value and manage capital efficiently.
British American Tobacco has announced a series of transactions by its Executive Directors and key managerial personnel involving the purchase of ordinary shares under the Partnership Share Scheme, an HMRC approved Share Incentive Plan. This move, involving leaders such as the Chief Executive and Chief Financial Officer, denotes a strong commitment to the company, potentially impacting its stock market performance positively by signaling confidence from top management.
British American Tobacco has executed a buyback program by repurchasing 123,948 of its ordinary shares, an action approved by shareholders at the previous Annual General Meeting. The repurchased shares are set to be canceled, reducing the total number of shares in circulation and potentially impacting shareholder value by increasing earnings per share. Following this transaction, the company will have over 2.2 billion shares with voting rights, indicating a strategic move to optimize its capital structure and enhance shareholder returns.
British American Tobacco p.l.c. announced that several of its executive directors and other key management personnel have acquired ordinary shares in the company as part of the British American Tobacco Share Incentive Plan. This acquisition, executed through the reinvestment of dividend income, reflects the company’s commitment to aligning the interests of its management with those of its shareholders. These transactions could potentially influence the company’s market perception and underscore management’s confidence in the company’s future performance.
British American Tobacco has announced the acquisition of ordinary shares by several of its high-ranking executives through the reinvestment of dividend income. This acquisition, involving directors and executives such as Michael Dijanosic, James Murphy, David Waterfield, and Javed Iqbal, took place on February 3, 2025, on the London Stock Exchange. This move highlights the company’s ongoing commitment to its stakeholders and could potentially reinforce confidence in its financial strategies and market stability.
British American Tobacco has announced a transaction involving its Chief Executive, Tadeu Marroco, who acquired quarterly dividend equivalent shares under the company’s Deferred Share Bonus Scheme. This transaction, involving 387 ordinary shares at a price of £32.00 each, reflects ongoing internal financial operations, potentially impacting executive compensation and shareholder value.
British American Tobacco has disclosed a transaction involving Non-Executive Director Holly Keller Koeppel, who was credited with additional Deferred Stock Units (DSUs) linked to the value of the company’s American Depositary Shares (ADSs). This transaction reflects the company’s ongoing efforts to align managerial incentives with shareholder interests, potentially impacting stakeholder perceptions and reinforcing the company’s commitment to executive compensation linked to performance.
British American Tobacco has executed a buyback program, purchasing 126,120 of its own shares at an average price of 3,212.1205 pence each. The acquisition and subsequent cancellation of these shares aim to optimize capital structure and could potentially enhance shareholder value. Following the transaction, the company’s issued share capital stands adjusted, impacting shareholders’ disclosures under the FCA’s rules.
British American Tobacco has executed a share buyback as part of its ongoing repurchase program, buying 127,664 ordinary shares at a volume weighted average price of 3,198.3504 pence per share. These shares will be canceled, reducing the number of shares in circulation and potentially enhancing shareholder value. The purchase aligns with the authority granted by shareholders and impacts the company’s financial structure as it continues to manage its capital allocation strategy.
British American Tobacco p.l.c. has announced its issued share capital as of January 31, 2025. The company reported 2,207,010,986 ordinary shares with voting rights, while holding 133,266,206 shares in treasury. This figure is crucial for shareholders to calculate their voting rights interest as per FCA rules.
British American Tobacco has announced a transaction involving the repurchase and cancellation of 121,370 of its ordinary shares as part of a buyback program. This action is in line with the authority provided by its shareholders and could potentially impact the company’s share value and market positioning, as it reduces the number of shares in circulation.
British American Tobacco p.l.c. announced a notification of major holdings indicating a change in voting rights involving Standard Bank Group Limited. The notification reflects an acquisition or disposal of voting rights, with a resulting position of 3.35% of voting rights attached to shares. This development could influence the company’s governance dynamics and potentially impact shareholder decision-making processes.
British American Tobacco announced a share buyback, purchasing 121,715 of its ordinary shares at an average price of 3,172.3411 pence per share, as part of its ongoing buyback program. This move, which involves canceling the purchased shares, aims to reduce the company’s total share count, potentially enhancing shareholder value by increasing earnings per share and impacting its market positioning.
British American Tobacco has proceeded with a share buyback program, acquiring 116,102 of its ordinary shares at prices ranging from 3,143.00p to 3,184.00p per share. This move, executed through Merrill Lynch International, is part of a broader strategy to enhance shareholder value, with the purchased shares set to be canceled. The buyback impacts the company’s share capital, reducing the number of shares in circulation, which could influence shareholder voting rights and regulatory disclosure requirements.
British American Tobacco p.l.c. announced the purchase of 122,045 of its ordinary shares as part of its ongoing buyback program, with the intention to cancel the purchased shares. This move, authorized by shareholders, is part of a strategy to optimize capital structure and potentially enhance shareholder value, affecting the total number of shares in issue and possibly impacting shareholder interests under regulatory disclosure requirements.
British American Tobacco p.l.c. has repurchased 124,498 ordinary shares as part of its ongoing buyback program, with plans to cancel the shares to adjust its capital structure. This strategic move, authorized by shareholders, reduces the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests by aligning with market regulations.
British American Tobacco has executed a share buyback program, purchasing 129,541 ordinary shares at an average price of 2,995.1908 pence per share. This move, authorized by shareholders, is part of its broader strategy to enhance shareholder value by reducing the number of shares in circulation, which could potentially impact the company’s stock value and stakeholder interests.
British American Tobacco recently announced an update regarding a previous transaction involving its Chief Corporate Officer, Kingsley Wheaton. The update disclosed that an additional 1,011 ordinary shares were transferred to his spouse, Julia Wheaton, which was not included in the original report due to an oversight. This transaction reflects internal compliance and transparency efforts within the company, ensuring accurate disclosure of managerial dealings.
British American Tobacco has announced the repurchase of 128,750 ordinary shares as part of its ongoing buyback program. The shares, purchased at an average price of 2,992.2105 pence, are set to be canceled, which will reduce the total number of shares in circulation. This move is part of the company’s efforts to optimize capital structure and enhance shareholder value, potentially impacting its stock value and market perception.
British American Tobacco announced the purchase of 129,078 ordinary shares as part of its ongoing buyback program. These shares were acquired at a volume weighted average price of 2,963.1466 pence each and are intended to be canceled, impacting the company’s total shares in issue. This move is part of the company’s strategy to manage capital and potentially enhance shareholder value.
British American Tobacco announced the repurchase of 131,632 of its ordinary shares as part of its ongoing buyback program. This move, facilitated by Merrill Lynch International, is in line with shareholder authorization from the company’s annual meeting and aims to cancel these shares, thereby potentially increasing the value of remaining shares and adjusting the company’s share capital structure.
British American Tobacco announced the repurchase of 131,496 ordinary shares as part of its ongoing buyback program, with plans to cancel these shares. This action will result in 2,207,891,794 ordinary shares remaining in circulation, impacting shareholder interests by potentially altering voting rights and share value dynamics.
British American Tobacco p.l.c. announced the purchase and cancellation of 131,455 of its ordinary shares as part of its previously announced buyback programme. This action reduces the total number of shares in circulation, potentially increasing the value of remaining shares and signaling confidence in the company’s financial stability, which may impact investor perceptions and market positioning.
British American Tobacco announced the repurchase of 134,079 ordinary shares at an average price of 2,904.6775 pence per share as part of its ongoing buyback program. This move is aimed at reducing the number of shares in circulation, potentially increasing the value of remaining shares and benefiting shareholders. Following the completion of this transaction, the company will have 2,208,154,745 shares outstanding, with 133,266,206 held in treasury, thereby impacting shareholders’ notifications under regulatory guidelines.
British American Tobacco has announced a change in the voting rights composition involving The Capital Group Companies, Inc., which now holds 15.075429% of the voting rights, up from a previous 14.040509%. This adjustment in holdings indicates a notable change in the stakeholder landscape of the company, potentially impacting its governance and decision-making processes.
British American Tobacco has executed a share buyback transaction, purchasing 134,138 of its ordinary shares at an average price of 2,899.5993 pence per share, as part of its broader buyback program authorized by shareholders. This strategic move is aimed at reducing the number of shares in circulation, thereby potentially increasing shareholder value and impacting the company’s equity structure.
British American Tobacco announced the purchase of 132,478 ordinary shares as part of its buyback program, with the intention to cancel these shares. This move, following shareholder approval, reduces the total number of shares available in the market, potentially increasing shareholder value and impacting voting rights.
British American Tobacco has executed a share buyback as authorized by its shareholders, purchasing 131,233 of its ordinary shares through Merrill Lynch International. The company intends to cancel these shares, which will affect the total number of shares in issue and may require shareholders to review their interest in the company under FCA regulations.
British American Tobacco p.l.c. announced the repurchase of 129,296 of its ordinary shares as part of a previously announced buyback program. The shares were purchased from Merrill Lynch International, with the highest price paid per share being 2,993.00 pence and the lowest at 2,956.00 pence. The company intends to cancel these shares, which will result in a total of 2,208,684,947 ordinary shares in issue, excluding those held in treasury. This transaction is part of the company’s strategic effort to enhance shareholder value and manage its capital structure more effectively.
British American Tobacco announced the repurchase of 125,270 of its ordinary shares as part of its ongoing share buyback program. The company plans to cancel these shares, reducing the number of shares in circulation, which can impact shareholder interests under the FCA’s rules. This move may strengthen the company’s share value and demonstrate confidence in its financial position.
British American Tobacco has executed a share buyback, acquiring 113,409 of its ordinary shares at an average price of 2,957.0886 pence per share. This transaction, part of a previously announced buyback program, aims to cancel the purchased shares, potentially impacting the company’s share capital structure and stakeholder interests by altering voting rights and shareholding proportions.
British American Tobacco has executed a share buyback program, purchasing 105,667 ordinary shares at a weighted average price of 2,957.1 pence each. These shares will be canceled, resulting in an updated number of 2,209,052,103 ordinary shares in issue. This move is part of the company’s strategy to manage its capital efficiently and could impact shareholder notifications regarding their interests in accordance with the FCA’s Disclosure Guidance and Transparency Rules.
British American Tobacco has repurchased 105,896 of its ordinary shares as part of its ongoing buyback program, with plans to cancel the acquired shares. This move reflects the company’s efforts to optimize its capital structure and potentially enhance shareholder value, while the updated number of shares in issue may affect shareholder notification requirements under regulatory rules.